EpiMonitor

Next-Gen Epilepsy Monitoring

Available in the US, UK, EU, AU, NZ and CA

Embrace2

Embrace2

Peace of Mind

No longer available for purchase

Empatica Logo
  • Solutions

    Empatica Health Monitoring Platform

    Empatica Health Monitoring Platform

    One platform, multiple applications

    Components

    EmbracePlus wearable
    EmbraceMini wearable
    New
    Care software suite
    eCOA
    Digital biomarkers
    Cloud API for Clinical Trials

    Use Cases

    Clinical Trials
    Designed for the patient, enhanced for the scientist
    Actigraphy
    The new standard to measure sleep and physical activity
    Contract Research Organizations
    Enhanced value and effortless integrations for CROs
    Parkinson's Monitoring
    New
    Improve patient outcomes with validated PKG measures
    Academic Research
    Unlock the future of real-world research
    Go to store
  • Scientific Evidence

    Publications
    Scientific publications using our technology
    Case Studies
    Client success stories
  • Resources

    Compliance
    Global regulatory requirements
    Blog
    Thoughts and news
    Digital resources library
    Online and downloadable resources
    Support center
    Get support with our products
  • Company

    About us
    People with purpose
    Careers
    Join the mission
    Contact us
    Talk to our team
Contact Us
Empatica Logo
Empatica Health Monitoring Platform

Empatica Health Monitoring Platform

One platform, multiple applications

Components

EmbracePlus wearable
EmbraceMini wearable
New
Care software suite
eCOA
Digital biomarkers
Cloud API for Clinical Trials

Use Cases

Clinical Trials
Designed for the patient, enhanced for the scientist
Actigraphy
The new standard to measure sleep and physical activity
Contract Research Organizations
Enhanced value and effortless integrations for CROs
Parkinson's Monitoring
New
Improve patient outcomes with validated PKG measures
Academic Research
Unlock the future of real-world research
Go to store
Publications
Scientific publications using our technology
Case Studies
Client success stories
Compliance
Global regulatory requirements
Blog
Thoughts and news
Digital resources library
Online and downloadable resources
Support center
Get support with our products
About us
People with purpose
Careers
Join the mission
Contact us
Talk to our team
EpiMonitor

Next-Gen Epilepsy Monitoring

Available in the US, UK, EU, AU, NZ and CA

Embrace2
Embrace2

Peace of Mind

No longer available for purchase

Contact Us
News

Exploring new frontiers to predict respiratory infections

Empatica

Empatica

Feb 20, 2019• 4 min read

LinkedinFacebookX

The peak of flu season is upon us, and each year the wave seems to grow more intense. The first sign of a sore throat or stuffiness may signal that it’s already too late to ward off the virus. What if you could spare yourself the coughing, chills, and fatigue, by receiving an alert on your phone before symptoms even start to develop?

Since the outset, we’ve been focused on developing breakthrough technology to improve and possibly save lives. The majority of our work has been on epilepsy, seeking to understand the problems and struggles faced by people with epilepsy, and provide wearable health solutions that ease the burden and help them live more independently. We’re now excited to expand our research in health sensor technology to assist other areas of need.

Broadening the reach of our novel technology

We've partnered with the U.S. government through DRIVe, a division of the The U.S. Department of Health and Human Services, that brings together the best ideas from medical and scientific communities, with government investment, to transform health security. With their collaboration, we’ll start working on a research project to develop a new smart watch to alert users when they’re developing a serious lung infection, even before any symptoms appear.

To do this, we will investigate the use of the same advanced machine learning technology housed in our FDA-cleared Embrace2, to monitor physiological signals that suggest the person is getting ill, and subsequently alert users and their caregivers.

Our Chief Scientist and Co-founder, Rosalind Picard, describes the potential impact of the project, “Imagine if your future smart watch could tell you your body is fighting sickness before you have any obvious symptoms— and that if you go to sleep two hours early tonight and drink a special beverage you would have 70% less chance of coming down with the flu tomorrow — how would your life be improved? Multiply that by 49M people in the U.S. who had influenza in 2018 — how would our world be improved?”

The global burden of respiratory infections

A runny nose, hacking cough, and red watery eyes are annoying effects of the flu most of us are familiar with. They strike on average 5 to 20 percent of the US population each year. Everyone has their own remedy, and it's generally no cause for alarm. However, combatting the virus can be much more severe for certain populations, such as young children, pregnant women, and especially the elderly. Serious flu-related complications can lead to hospitalization, and sometimes even death. The CDC estimates that the 2017-2018 influenza season resulted in 959,000 hospitalizations and 79,400 deaths. Older adults accounted for 70% of the death and 90% of the deaths.

Grand-scale impact

By being able to detect respiratory infections, patients can receive the medicine they need to keep them healthier, and this in turn could stop the infection from traveling and spreading to others. We believe that innovative medical technology should be widely available to the general public, which is why are dedicated to building smart wearable solutions that are in sync with your health. While our focus on helping people with epilepsy will continue to be at the forefront of what we do, we're looking forward to unlock the power of our technology to address a broader range of conditions and illnesses.

Words worth reading

Read more

We do not guarantee that EpiMonitor will detect every single seizure and deliver alerts accordingly. It is not meant to substitute your current seizure monitoring practices, but rather to serve as a supplement in expediting first-response time.

Company
About us
Careers
Legal
Blog
Empatica Health Monitoring Platform
Clinical Trials
Academic Research
Actigraphy
Parkinson's Monitoring
Log in
Care Portal
Care Lab Portal
Research Portal
Epilepsy Monitoring
EpiMonitor
Embrace2
Get Support
Contact Us
Manuals
Empatica
FacebookInstagramYouTubeTwitterLinkedin

Empatica Inc., 1 Broadway, 14th floor, Cambridge MA 02142 United States - Empatica Srl, Via Stendhal 36, 20144 Milano (MI), Italy

P. IVA IT07462810966. Copyright © 2026 Empatica Inc. - ISO 13485 Cert. No. 39050072201 - All rights reserved - Legal